Viridian Therapeutics Inc... (VRDN)
12.66
-0.41 (-3.14%)
At close: Apr 03, 2025, 3:59 PM
12.65
-0.08%
After-hours: Apr 03, 2025, 04:05 PM EDT
Viridian Therapeutics Analyst Ratings
Total Analysts
12
Consensus Rating
Buy
Price Target
34
Upside
168.56
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| Needham | Buy | Reiterates | 38 38 | 200.16% | Jan 7, 2025 | |
| Wells Fargo | Hold | Downgrades | 27 | 113.27% | Dec 19, 2024 | |
| RBC Capital | Buy | Maintains | 44 47 | 271.25% | Dec 17, 2024 |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.